Alphabet’s biolab in funding talks at $40B valuation
The company hopes the new investment will accelerate its push to develop new drugs.
We haven't written up this one. Semafor has the full story — the link below goes straight to it.
More in Finance & Markets
Tinubu pushed for African credit rating agency, aide says
An aide says President Bola Tinubu played a role in pushing for the new Africa Credit Rating Agency (AfCRA), which has been launched in Mauritius by the AU Read More…
Tinubu pushed for African credit rating agency, aide says
An aide says President Bola Tinubu played a role in pushing for the new Africa Credit Rating Agency (AfCRA), which has been launched in Mauritius by the AU Read More…
Prediction: These 2 Stocks Will Be Worth More Than Palantir 5 Years From Now
Under-the-radar AI suppliers Celestica and Marvell are posting explosive growth, and their valuations still have plenty of room to run.
India's Sensex slumps to 32-month low on oil surge, foreign exodus
India’s benchmark Sensex slumped to its lowest in 32 months on Thursday as surging oil prices, rising global bond yields and a weaker rupee heightened inflation concerns, adding to pressure from the…
Arianne Phosphate Receives Positive Test Results From a Battery Materials Producer
SAGUENAY, Quebec, Oct. 08, 2026 (GLOBE NEWSWIRE) — Arianne Phosphate (the “Company” or “Arianne”) (TSX VENTURE: DAN; OTCQB: DRRSF; FRANKFURT: JE9N), a development-stage phosphate mining company…
Banken: Crédit Agricole will Deutschlandgeschäft stärken – und nimmt auch Zukäufe in den Blick
Die französische Bank plant, ihren deutschen Kundenstamm in den kommenden zwei Jahren auf zwei Millionen zu verdoppeln. Um das Mittelstandsgeschäft zu stärken, sind externe Zukäufe denkbar.